A new paper explains how faulty leads in medical devices got onto the market, shedding light on a little-known process used by manufacturers to alter medical devices without putting them through human trials. Aaron S. Kesselheim, assistant professor of medicine at Brigham and Women’s Hospital, is the senior author on the paper.
